[home]
[thesaurus]
Click Here to return To Results
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
See this aricle in Pubmed
Article Abstract
No abstract available for this article
Related Tags
(click to filter results - removes previous filter)
atogepant
calcitonin gene-related peptide receptor blocker
efficacy
headache
migraine
migraine,chronic
migraine,prophylaxis
migraine,treatment of
prevention of neurologic disorders
safety
treatment of neurologic disorder
Click Here to return To Results